… No written consent was needed for this work in accordance with the “LOI n 2004-800 relative
à la bioéthique” published in the “Journal Officiel de la République Française” the 6 August …

Spinal muscular atrophy (SMA) causes a predominantly bilateral proximal muscle weakness
and atrophy. The respiratory muscles are also involved with a weakness of the intercostal …

The increase in life expectancy of patients with cystic fibrosis has come with new comorbidities,
particularly diabetes. The gradual development of glucose tolerance abnormalities …

… N. Stremler reports advisory board participation with Vertex, outside the submitted work. B.
Douvry reports grants and advisory board participation with Vertex, outside the submitted work…

Recent studies using 16S rRNA gene amplification followed by clonal Sanger sequencing in
cystic fibrosis demonstrated that cultured microorganisms are only part of the infecting flora. …

… No written consent was needed for this work in accordance with the "LOI n 2004-800 relative
à la bioéthique" published in the "Journal Officiel de la République Française" the 6 August …

Objectives Lumacaftor–ivacaftor is a cystic fibrosis transmembrane conductance regulator (CFTR)
modulator known to improve clinical status in people with cystic fibrosis (CF). The aim …

Objectives The aim of the study was to evaluate sleep quality and nocturnal gas exchange
in patients with cystic fibrosis (CF) and to assess if sleep quality and daytime lung function …

Introduction Cystic fibrosis afflicted lungs support the growth of many bacteria rarely
implicated in other cases of human infections. Case presentation We report the isolation and …

… December 2006 from 146 patients with CF (n = 356 sputum samples; 86 children, group 1;
and 60 adults, group 2) and from 56 patients without CF (n = 67 sputum samples; 18 children, …